Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126122121 | 12612212 | 1 | I | 20160111 | 20160617 | 20160801 | 20160801 | EXP | GB-OTSUKA-2016_018388 | OTSUKA | 21.00 | YR | M | Y | 0.00000 | 20160801 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126122121 | 12612212 | 1 | PS | ABILIFY MAINTENA | ARIPIPRAZOLE | 1 | Intramuscular | 1 DF, 1/1 MONTHS | U | 202971 | 1 | DF | SUSPENSION FOR INJECTION | /month | |||||
| 126122121 | 12612212 | 2 | C | INSULIN | INSULIN NOS | 1 | Unknown | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126122121 | 12612212 | 1 | Product used for unknown indication |
| 126122121 | 12612212 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126122121 | 12612212 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126122121 | 12612212 | Injection site mass | |
| 126122121 | 12612212 | Pain | |
| 126122121 | 12612212 | Purulence | |
| 126122121 | 12612212 | Sciatica | |
| 126122121 | 12612212 | Septic embolus |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126122121 | 12612212 | 1 | 20160109 | 0 |